Hormonal
Tirzepatide, a dual GLP-1 and GIP receptor agonist, produces significant weight loss (exceeding 20% body weight in some cases) and improves glycemic control in patients with type 2 diabetes and obesity.
Tirzepatide is a weekly injection that mimics gut hormones to significantly reduce weight (often >20%) and improve blood sugar. It works best when paired with diet and exercise. Start with lower doses to minimize stomach issues like nausea, which usually improve over time.
Os ensaios clínicos revisados demonstram que a Tirzepatida, um agonista duplo dos receptores GLP-1 e GIP, não apenas melhora o controle glicêmico em pacientes com diabetes tipo 2, mas também promove uma redução de peso considerável, com perdas superiores a 20% do peso corporal em alguns casos.
Why this rating
Based on an integrative review of 10 studies including phase 3 trials (SURPASS, SURMOUNT), though not a single primary RCT itself.
Source
O USO DE TIRZEPATIDA NO COMBATE A OBESIDADE: UMA ANÁLISE DOS BENEFÍCIOS E EFEITOS ADVERSOS
Vinicius Camilo Gomes dos Ramos et al. · Revista interdisciplinar em saúde · 2024
DOI 10.35621/23587490.v11.n1.p500-515
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →